Second Opinion August 22, 2024
Not all companies (or hormones) are created equal
This piece was written by obstetrician gynecologist Dr. Barbara Levy, with support from our new women’s health editor Leslie Schrock. Schrock is also the author of the brilliant women’s health newsletter Fertility Rules.
Menopause is one of the hottest growth areas in healthcare, with more than $500 million in venture capital funding flowing into the sector since 2015, plus many headlines about the gap in care. But the path to the front page hasn’t been easy.
Nor has the path to getting women effective treatment. Hormone replacement therapy (HRT) – or as it is also known, menopause hormone therapy (MHT) – has a fraught history of flawed research...
Today's Sponsors
Today's Sponsor